Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03151928 · ClinicalTrials.gov registry record
Diagnostic Accuracy By Providers Study
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 299
- Enrollment target
NCT03151928: Completed study, sponsored by University of Pittsburgh.
NCT03151928 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 299 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03151928 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 299 participants
- Enrollment target
Study Summary
The validation study is intended to provide comparative data on the diagnosis of vaginal infections as performed in primary care settings versus the diagnosis provided through standard diagnostic testing performed in a reference laboratory. The clinician and lab diagnoses will be compared to those obtained using the BD MAX Vaginal Panel on the BD MAX System.
Primary Outcome
Comparison of the level of agreement of clinician diagnosed BV to vaginal swab samples evaluated for BV using Nugent's criteria and the BD MAX Vaginal Panel
Interventions
- DIAGNOSTIC_TEST BDMax Vaginal Panel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2017-07-06 |
| Est. Completion | 2018-08-15 |
What the finished NCT03151928 record still lists
NCT03151928 is an observational study that tracks outcomes without assigning an intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which BDMax Vaginal Panel is the first listed.
NCT03151928 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03151928 about?
NCT03151928 is a clinical study titled "Diagnostic Accuracy By Providers Study". The validation study is intended to provide comparative data on the diagnosis of vaginal infections as performed in primary care settings versus the diagnosis provided through standard diagnostic testing performed in a reference laboratory. The clinician and lab diagnoses will be compared to those o...
What is the current status of trial NCT03151928?
This trial is currently completed. The enrollment target is 299 participants. The study started on 2017-07-06. Estimated completion is 2018-08-15.
What interventions are being tested in trial NCT03151928?
The interventions under investigation include: BDMax Vaginal Panel (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03151928?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI